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Summary 
We report the purification of a protease from tumor cells undergoing apoptosis that is involved 
in activating DNA fragmentation. Initial studies revealed that two inhibitors of serine proteases, 
N-l-tosylamide-2-phenylethylchloromethyl  ketone and carbobenzoxy-Ala-Ala-borophe (DK120), 
suppressed tumor necrosis factor or ultraviolet (UV) light-induced DNA fragmentation in the 
U937 histiocytic  lymphoma as well as UV light-induced DNA fragmentation in the BT-20 
breast carcinoma,  HL-60 myelocytic leukemia, and 3T3 fibroblasts. The protease was purified 
by affinity chromatography with DK120 as ligand and showed high activity on a synthetic substrate 
preferred by dastase-like enzymes (Ala-Ala-Pro-Valp-nitroanilide), but was inactive on the trypsin 
substrate, N-ol-benzyloxycarbonyl-t-lysine  thiobenzyl ester, or the chymotrypsin substrate, Ala- 
Ala-Pro-Phep-nitroanilide.  The activity of the DK120-binding protease purified from U937 cells 
undergoing apoptosis was increased '~10-fold  over that recovered from normal cells. Further 
purification to homogeneity by heparin-Sepharose  affinity chromatography followed by reverse 
phase high-performance liquid chromatography revealed a single band of 24 kD on a silver-stained 
sodium dodecyl sulfate gel. In addition to protease activity, the purified enzyme induced DNA 
fragmentation into multiples of 180 basepairs in isolated U937 nuclei. These findings suggest 
the 24-kD protease is a novel enzyme that activates DNA fragmentation in U937 cells undergoing 
apoptosis. 
s 
is the normal physiological process of cell death 
that functions to control cell populations  during em- 
bryogenesis, immune responses, hormone withdrawal from 
dependent tissues, and normal tissue homeostasis (for review 
see references 1-3).  Unlike necrosis, during apoptosis,  en- 
donucleases present  in the cell cut the DNA in the linker 
regions  to release DNA fragments  in multiples  of 180 bp 
(4). However the biochemical basis of signal transduction as 
well as the identification of the relevant nudease(s) have not 
yet been elucidated. Our relatively limited understanding of 
the mechanism of apoptosis suggests it may differ depending 
on the cell type and inducing agent.  Some (4-6) but not all 
(7, 8) examples of apoptosis require new gene expression and 
protein synthesis. Differences have also been reported in the 
requirement for extracellular calcium (4, 9-11). These findings 
may reflect diverse signaling events functioning at early stages 
of a pathway that subsequently converge to a final biochem- 
ical response common to many or all forms of apoptosis. 
Our laboratory has been studying the mechanism of apop- 
tosis using primarily the human histiocytic lymphoma, U937, 
as a model system. This cell line undergoes apoptosis in re- 
sponse to a variety of stimuli, including TNF, UV light, heat 
shock, oxidative stress, and chemotherapeutic drugs (12, 13). 
Most of our studies have used TNF or UV light, which rap- 
idly (within 2-3 h) induce apoptosis in U937 cells. In this 
system, one can prepare populations  in which I>90% of the 
cells are undergoing apoptosis, and thus U937 is a valuable 
resource for identifying, isolating, and characterizing enzymes 
activated during this process. Thus far, our studies indicate 
that both TNF and UV light activate signals converging to 
a final common pathway leading to DNA fragmentation. This 
process does not require protein synthesis (12) or extracel- 
lular calcium, in agreement with a previous report (14). PMA 
inhibits  apoptosis induced by TNF (15) or UV light, sug- 
gesting a regulatory role for protein kinase C in agreement 
with other examples of apoptosis (16-20). Augmentation of 
intracellular protein phosphorylation by inhibitors of serine/ 
threonine-dependent phosphatases promoted TNF-induced 
apoptosis and overcame the resistance of a U937 variant (21), 
suggesting  a critical role for protein kinases in signal trans- 
duction. This is further supported by the finding that an in- 
hibitor of certain serine/threonine-dependent protein kinases 
(KT5926) blocked TNF- (21) and UV light-induced apop- 
tosis (our unpublished observations).  However, the specific 
kinase involved has not yet been identified. Apoptosis in U937 
cells is also blocked by 3-aminobenzamide (12), an inhibitor 
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increased levels of pADPKp activity have been measured in 
lysates of TNF- or UV light-treated U937 cells (Wright, 
S.  C.,  Q.  S. Wei, J. Zhong,  and H.  Zheng, manuscript in 
preparation).  These findings  are in  agreement  with  other 
reports of activation of pADPRp in cells in response to TNF 
(22). Whether this enzyme functions to activate endonudeases 
or contributes to cell death through depletion of NAD (23, 
24) has not yet been established. 
This study was undertaken to examine the role of proteases 
in signal transduction leading to DNA fragmentation. It was 
found that certain inhibitors of serine proteases block TNF- 
or UV light-induced apoptosis in several tumor cell lines. 
Furthermore, we purified to homogeneity a 24-kD protease 
that was activated by UV light in U937 cells and induced 
internucleosomal DNA  fragmentation in isolated nuclei. 
Materials  and Methods 
Cell Lines.  The human histiocytic lymphoma, U937, the human 
mammary carcinoma BT-20, the human myelocytic leukemia Hb 
60, and the routine fibroblast cell line 3T3 were obtained from Amer- 
ican Type Culture Collection (Rockville, MD). All cell lines were 
maintained in antibiotic-free RPMI 1640 supplemented with 10% 
FCS and L-glutamine (2 raM). All cell lines were routinely tested 
for mycoplasma and always found to be negative according to the 
Mycotect kit (GIBCO BILL, Gaithersburg, MD). 
Reagents.  Purified human rTNF  (sp  act  =  107 U/rag)  was 
purchased from K&D Systems,  Inc.  (Minneapolis,  MN). DNase 
I was purchased from Worthington Biochemical Corp. (Freehold, 
NJ), and micrococcal nuclease (116 U/mg) was from Calbiocbem 
Corp. (San Diego, CA). All substrates  for the protease assays and 
protease inhibitors (except DK120) were purchased from Sigma 
Chemical Co. (St. Louis, MO). Trypsin and chymotrypsin were 
obtained from Sigma Chemical Co., and human leukocyte elastase 
was from Calbiochem Corp. 
DNA Fragmentation Assay.  This assay was described in detail 
previously (12). Briefly, target cells were labeled with [3H]thymi- 
dine (5 Ci/mmol) and plated in triplicate in flat-bottomed micro- 
titer plates. Cells were incubated for the indicated length of time 
for each experiment in the presence of TNF or various inhibitors. 
In some experiments, cells were treated with UV light at 245 nm 
by use of a UV cross-linker (Fisher Scientific Co., Pittsburgh, PA). 
Assays were terminated and the radioactivity counted on a beta 
counter (model Matrix 96; Packard Instrument Co., Inc., Meriden, 
CT). Percent DNA fragmentation was calculated  as for the nu- 
clear assay described below. In assays to test the effects of various 
inhibitors, the pH of extra wells containing assay  buffer, target cells, 
and each inhibitor was always checked at the beginning and end 
of each assay to ensure that the pH remained at 7.5. The sponta- 
neous release of [3H]thymidine relative to the total counts at the 
initiation of the assay ranged from 0 to 1.7%/h for up to 8 h. 
DNA Fragmentation Assay Using U937 Nuclei  Targets.  U937 
cells were labeled with [3H]thymidine by culturing overnight with 
isotope at 0.5 #Ci/ml. The cells were pelleted, washed once, and 
1 Abbreviations used in this paper: BLT, N-ot-benzylexycarbonyl-t-lysine 
thiobenzyl ester; DK120, carbobenzoxy-Ala-Ah-borophe;  DMF, dimeth- 
ylformamide; ICE, IL-1/~-converting  enzyme; MAAPV, meth~odsuccinyl- 
Ala-Ala-Pro-Val p-nitroanilide; pADPKp, poly ADP-ribose polymerase; 
SAAPP, succinyl-Ala-Ala-Pro-Phep-nitroanilide;  TPCK, N-l-tosylamide- 
2-phenylethylchloromethyl  ketone. 
the cytoplasmic membrane lysed by resuspending the cells in assay 
buffer (50 mM "Iris, 250 mM sucrose,  10 mM MgSO4, pH 7.5) 
plus 0.02% NP-40. Nuclei were then pelleted and resuspended in 
assay buffer at 106/ml. The assay was  set up in triplicate in flat- 
bottomed microtiter plates under sterile conditions. Nuclei (0.05 
ml) were mixed with 0,05 ml of sample diluted in 50 mM Tris, 
pH 7.5, or buffer alone to determine total counts. Plates were in- 
cubated for 5 h at 37~  and then harvested by the addition of 0.1 
ml of harvesting buffer (10 mM Tris, 10 mM EDTA, 0.3% Triton 
X-100, pH 7.5). High molecular weight DNA was collected by 
filtration onto glass fiber paper, and the radioactivity counted on 
a Matrix 96/~ counter. Percent DNA fragmentation was calcu- 
lated as follows: [(total cpm-test cpm)/total cpm]  x  100. The spon- 
taneous release of [3H]thymidine relative to the total counts at the 
initiation of the assay did not exceed 2%/h for up to 7 h. 
Visualization of DNA Fragmentation of Gel Electrophoresis.  This 
assay was described in detail previously (12). The assay was adapted 
to assess the effects of compounds on DNA fragmentation in iso- 
lated nuclei. Nuclei were prepared from normal unlabeled U937 
cells as described above. After the desired treatments of aliquots 
of 5  x  106 nuclei, 1.0 ml of harvesting buffer was added,  and de- 
bris was removed by centrifugation at 13,000 g for 10 s. DNA in 
the supernatant was ethanol precipitated after phenol extraction. 
Equivalent amounts of material from a fixed number of ceils were 
loaded and electrophoresed on a 1.0% agarose slab gel. DNA was 
visualized  by ethidium bromide staining. 
Nuctease Assay with  U937 DNA as Substrate.  [3H]thymidine- 
labeled DNA was prepared by incubating U937 ceils with isotope 
at 0.5/~Ci/ml for 24 h. The cells were washed,  and DNA was 
isolated  according to a previously published procedure (25).  3H- 
labeled U937 DNA was diluted to 75 #g/ml in 50 mM Tris, 10 
mM MgSO4, 1 mM CaC12, pH 7.5.0.05 ml of substrate and 0.05 
ml of sample were mixed in Eppendorf tubes and incubated at 37~ 
for 20 h. The assay was terminated by the addition of 0.05 ml of 
0.5% BSA plus 0.05 ml of 7% perchloric acid and placed on ice 
for 15 rain.  The intact DNA was  pelleted by centrifugation at 
13,000 g for 15 rain, and the radioactivity in 0.1 ml of the superua- 
tant was assessed by scintillation counting. The percentage of DNA 
fragmentation was calculated as the counts per minute in the su- 
pernatant divided by the total counts per minute of the original 
DNA added  x  100. 
Protease Assays.  Proteolytic activity was assayed with synthetic 
substrates  selective for different known proteases. All assays were 
set up by adding 0.02 ml of sample at the desired concentration 
(or known enzyme as a positive control) plus 0.18 ml of appro- 
priate substrate  dissolved  in PBS, pH  7.5,  in  triplicate in  flat- 
bottomed microtiter plates. After incubation for the indicated length 
of time at room temperature, the OD at 405 nm was measured 
with a plate reader. 
To measure chymotrypsin-like activity, we used N-succinyl-Ala- 
Ala-Pro-Phe p-nitroauilide  (SAAPP)  at 0.1  mM  as  a  substrate. 
Trypsin-like activity was measured by use of N-c~-benzyloxycarbo- 
nyl-t-lysine thiobenzyl ester (BLT) at 0.2 mM plus 0.11 mM nitro- 
benzoic acid. 
Elastase-like activity was measured with N-methoxysuccinyl-Ala- 
Ala-Pro-Val p-nitroanilide (MAAPV) at 0.25 mM used as a sub- 
strate. For convenience and maximum sensitivity, these assays were 
routinely incubated for 20 h to monitor protease purification. Under 
these conditions, the dose response of commercially obtained leu- 
kocyte elastase  was  linear  up  to  a  concentration  of 6  #g/ml, 
producing an OD405 of I in the protease assay. The activity of the 
protease  samples  tested  during  purification  did  not  exceed  an 
OD4os of 1 under these assay conditions. 
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were set up, but kinetic readings of OD40s were taken every hour 
from 1 to 6 h. 1 U of  enzyme activity was calculated as the amount 
of enzyme that hydrolyzes 1 nM substrate/h. 
Asp-ase activity  was measured  by use of  the tert-butyloxycarbonyl- 
Ala-Ala-Asp-thiobenzyl  ester substrate (Enzyme Systems  Products, 
Dublin, CA). Protease samples (0.02 ml) were added to 0.18 ml 
assay  buffer containing 0.1 M Hepes, pH 7.0, 0.3 M NaC1, I mM 
EDTA, 0.11 mM dithiobis(2-nitrobenzoic acid), and 0.1 mM sub- 
strate and incubated at room temperature for 20 rain before reading 
optical density at 405  nm. A control for nonspecific indicator 
reduction was performed by omitting the substrate from the mix- 
ture. Negative controls contained all assay components except the 
protease. 
Preparation of DK120 Affinity Resin.  The synthesis and charac- 
terization of the boronic acid amino acid analogue protease inhib- 
itor (carbobenzoxy-ala-ala-borophe;  DK120) as well as the nonin- 
hibitory boronic acid compound isopropylboronic  acid (IBA), was 
described previously (26, 27). DK120 is a tripeptide reversible in- 
hibitor of chymotrypsin in which a boronic acid takes the place 
of  COOH at the site of enzymatic serine OH attack. Affinity resin 
was prepared in a manner similar to that described previously (28, 
29), except that epoxy-activated  Sepharose 6B was used instead of 
cyanogen bromide-activated resin (30). DK120 was N deblocked 
by hydrogenation in the presence of 5% Pd/carbon (10% weight) 
in 95% ethanol. Catalyst was removed  by filtration through celite, 
and the ethanol was evaporated. The resulting oily residue  was dried 
under  vacuum for at  least 1 h  to remove excess alcohol. The 
deprotected product was dissolved  in dimethylformamide (DMF) 
for coupling to the resin. Sepharose 6B (Sigma Chemical Co.) was 
swollen with water and then reacted with DK120 at pH 10 in 0.1 
M NaOH/DMF (1:1) for 16-24 h at 37~  The resin was subse- 
quently washed with DMF followed  by water. The derivatized  resin 
was then treated with 1 M ethanolamine at room temperature for 
4 h. The resin was then rinsed sequentially  with water, acetate  buffer, 
pH 4.0, and finally with borate buffer, pH 8.0. Affinity resin was 
stored in 20% ethanol until use. A control resin was prepared that 
lacked the DK120 ligand but was treated with ethanolamine and 
washed as described above. 
Preparation of Cell Lysates  for Protease Purification.  Normal or 
UV  light-treated  (0.2 J/cm  2 in  a  UV  cross-linker) calls were 
pelleted and resuspended at 2  x  10S/m1 in ice-cold lysing buffer 
(50 mM Tris, 0.3% NP-40, pH 7.0). The debris was pelleted by 
centrifugation in a microfuge at 14,000 g for 15 rain. The superua- 
tant was  used immediately or stored at  -70~  until further 
purification. 
DK120 Affinity Chromatography.  1 ml of affinity resin was 
equilibrated with starting buffer (50 mM Tris, pH 7.5, 100 mM 
NaC1, 1.0 mM CaCI2, 0.1% NAN3, 0.05% Tween 20). Cell ly- 
sate was mixed with the resin and allowed to bind for 60 min. 
The column was then washed with starting buffer at 0.5 ml/min 
until the OD2s0 returned to baseline. Bound material was eluted 
with starting buffer plus 0.1 M HC1, pH 4.5. During elution, 1- 
ml fractions were collected  and immediately  neutralized to pH 7.5. 
The column was regenerated by washing with 2 M NaC1 (no addi- 
tional protease was duted during this step). 
Hetmrin-Sepharose  Affinity Chromatography.  Heparin-Sepharose 
(Pharmacia Inc., Piscataway,  NJ) was equilibrated in starting buffer 
(50 mM Tris, pH 7.5, 1.0 mM CaC12, 0.05% Tween 20, 0.1% 
NAN3). Active fractions duted from the DK120 column were ap- 
plied and then washed with starting buffer at 0.5 ml/min until 
the OD2s0 returned to baseline. Bound material was eluted with 
a linear gradient from 0 to 2.5 M NaC1 in starting buffer. 1-ml 
fractions were collected and tested for protease activity. All flow- 
through fractions were negative for protease activity, whereas pro- 
teases showing activity against the MAAFV substrate eluted at 
1.0-1.5 M NaC1. 
Reverse Phase HPI.C,  Separations were performed on a liquid 
chromatography system (model 325; Waters Associates, Milford, 
MA) with a 3-cm x 2.l-ram cartridge (reverse  phase C4; Brownlee, 
Applied Biosystems, Inc., Foster City, CA). Buffer  A was water 
plus 0.1% TFA, and buffer B was 80% 2-propanol plus 0.1% TFA. 
Bound  material was  eluted by use  of a linear gradient  from 
75%A/25%B  to 35%A/65%B over 60 min at a flow rate of 0.2 
ml/min. 0.2-ml fractions were collected and immediately neutral- 
ized to pH 7.5. All fractions were tested for protease activity as 
well as nuclear DNA fragmenting activity. 
SDS-PAGE.  Protease  purity was assessed with 15% Laemmi 
SDS-PAGE followed by silver staining (Daiichi II kit; ISS, Hyde 
Park, MA). 
Amino Acid Analysis.  The amino acid composition was deter- 
mined at the Stanford University Medical Center Protein and Nu- 
cleic Add Facility  (Stanford, CA) by use of  an analyzer  (model  6300; 
Beckman Instruments, Inc., Fullerton, CA), Liquid phase hydrol- 
ysis was performed at 110~  for 24 h under vacuum. 
Results 
Certain Serine Protease Inhibitors Suppress DNA Fragmenta- 
tion in Cells Undergoing Apoptosis in Response to TNF or UV 
Light.  To examine the role of proteases  in the mechanism 
of apoptosis,  we tested the effects of a variety of protease in- 
hibitors on DNA fragmentation induced by TNF or UV light 
in the U937 cell line.  Two serine protease inhibitors, N-1- 
tosylamide-2-phenylethylchloromethyl  ketone (TPCK) and 
DK120, were found to be potent inhibitors of DNA frag- 
mentation. U937 cells were pretreated with the inhibitors 
for 1 h, then exposed to TNF (Fig.  1 A) or UV light (Fig. 
1 B) at doses  that preliminary studies established  to be in 
the linear portion of the dose-response curve. Both DK120 
and TPCK could dose dependently inhibit DNA fragmenta- 
tion, with maximum suppression occurring at 2 #M. TPCK 
is a known potent inhibitor of chymotrypsin-like enzymes, 
whereas DK120 is a boronic acid-containing tripeptide sub- 
strate analog that also potently inhibits chymotrypsin-like 
enzymes (26, 27). Isopropylboronic acid, a boronic acid analog 
devoid of protease inhibitory activity, does not inhibit DNA 
fragmentation (not shown), indicating that the inhibition 
by DK120 is not a property of any boron compound. 
Additional studies revealed that not all inhibitors of serine 
proteases can suppress DNA fragmentation since N-o~-p-tosyl- 
r-lysine-chloromethyl (TLCK), N-c~-p-tosyl-L-argine methyl- 
ester (TAME), PMSF, chymostatin, diisopropyl fluorophos- 
phate, benzamide, and leupeptin were without effect (data 
not shown). In addition, the inhibitor of sulfhydryl-dependent 
enzymes, N-ethylmaleimide, and the aminopeptidase inhib- 
itor bestatin, were inactive.  It should be noted that in this 
type of experiment, negative results are inconclusive since 
they may be due to inefficient penetration of the inhibitor 
to the presumably intracellular site of protease action. 
Further experiments were performed to determine if these 
findings were unique to U937 or if other cell lines also re- 
quire protease activity to undergo apoptosis.  We tested the 
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Figure  1,  Inhibition of DNA fragmentation induced by TNF (A) or 
UV light (B) by serine protease inhibitors. U937 target cells were pret~ated 
with the indicated concentrations  of inhibitors  for 1 h, and then exposed 
to either TNF 1.0 ng/ml plus cycloheximide 0.5 #g/ml (A) or UV light 
at 0.1 J/era  2 (/3). After incubation  for 2 h,  assays were terminated  and 
percentage of DNA fragmentatin  was determined.  The error bars repre- 
sent  the standard  deviations  of triplicate  values from one representative 
experiment  out of four total. 
effects of several inhibitors on apoptosis induced by UV light 
in the human mammary carcinoma BT-20, murine fibroblast 
cell line 3T3,  and human  myeloid leukemia HL-60 (Table 
1).  Since BT-20 and 3T3  cells  are not  as sensitive to UV 
Table  1.  Inhibition  of DNA Fragmentation by Protease 
Inhibitors in Several Cell Lines 
Percentage DNA Fragmentation* 
Inhibitor  BT-20  3T3  HL-60~ 
light-induced DNA fragmentation as HL-60 and U937 cells, 
they received a higher UV dose and longer incubation time. 
The results demonstrate that both TPCK and DK120 effec- 
tively blocked DNA fragmentation.  Taken altogether, these 
results support the hypothesis that  the activity of a serine 
protease(s) is essential for at least one apoptotic pathway oper- 
ating in different cell types responding to different stimuli. 
All inhibitors used in these studies were at nontoxic con- 
centrations for the duration of the assays, as determined by 
trypan blue exclusion. 
Affinity Purification of the U937 Protease.  Previous studies 
showed that  adsorption  to an immobilized protease inhib- 
itor can be used successfully to purify proteases (29). There- 
fore, to purify the putative apoptotic protease, a DK120 affinity 
column was prepared as described in Materials and Methods. 
Preliminary experiments verified that this matrix efficiently 
binds commercially available chymotrypsin, which could be 
eluted with 0.1 M HC1. After neutralization,  the eluted ma- 
terial still exhibited high levels of protease activity measured 
on the SAAPP substrate  (data not  shown). 
To prepare starting material,  U937 cells were exposed to 
UV  light  (0.2  J/cm ~)  and  incubated  at  37"C  until 
"~50-70%  of the cells exhibited the apoptotic morphology 
(this usually required 1.5-2 h incubation).  Numerous cyto- 
plasmic membrane blebs characteristic  of apoptosis were easily 
discernable by light  microscopy as documented previously 
(12). Cells were harvested at this time point while they were 
>95% viable by trypan blue exclusion, hov~ever, 90-100% 
of the cells were destined to die if the incubation were con- 
tinued another 2-3 h.  Cytoplasmic extracts were prepared 
from apoptotic as well as normal untreated U937 cells. Ma- 
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Figure  2.  DK120  affinity purification  of U937 protease.  Cell lysates 
were prepared from normal U937 cells (A) or UV light-pretreated cells 
(B), purified on DK120 columns as described in Materials and Methods, 
and  each  fraction  assayed for  protease  activity  (OD40s) against  the 
MAAPV substrate, 
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cells containing equal amounts of protein were chromato- 
graphed in an identical fashion on DK120 affinity columns. 
The results in Fig.  2 show that most of the protein as de- 
tected by absorption at 280 nm passed through the column 
in unbound fractions 2-17, whereas a relatively small amount 
of  material eluted with 0.1 M HC1. Proteolytic activity present 
in the eluted fractions was tested by use of several different 
synthetic substrates. The duate from UV light-irradiated cells 
showed high proteolytic activity against the dastase substrate, 
MAAPV, but relatively low activity against the chymotrypsin 
substrate, SAAPP, or the trypsin substrate, BLT. The affinity- 
purified protease from irradiated cells was also inactive on 
the  Asp-ase  substrate,  Ala-Ala-Asp-thiobenzyl ester  (not 
shown). The duate from the control ceUs showed low ac- 
tivity against all the substrates (data not shown). Therefore, 
proteolytic activity was monitored during protein purification 
with the MAAPV substrate.  To maximize sensitivity, this 
assay was carried out at room temperature for 20 h. How- 
ever, the dose response of commercially available leukocyte 
elastase was still linear up to an OD of 1, even at this prolonged 
incubation time (not shown). 
The profiles of protease activity showed high levels in the 
unbound fractions, suggesting that the columns may have 
been overloaded. However, when the flow-through fractions 
were pooled and reapplied to the DK120 column, all pro- 
tease activity was still  found in the unbound fractions and 
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Figure 3.  Kinetic assay to quantitate DK120-binding  protease. Active 
fractions of protease purified in the figure from normal U937 cells (.4) 
or UV light-treated cells (B) were pooled and tested in a kinetic protease 
assay against the MAAPV substrate. 
none in the eluate (data not shown). Therefore, it is con- 
cluded that lysates from both control and UV light-treated 
U937 cells contain substantial amounts of proteases that do 
not bind to the DK120 column. It is possible that proteases 
found in the unbound fractions were also activated during 
apoptosis.  However, since our primary objective was to char- 
acterize the DK120-binding protease, the enzymes in the un- 
bound fractions were not further analyzed in this study. 
The protease activity profiles  suggested that enzyme ac- 
tivity in the duate from UV light-treated cells was significantly 
increased over that recovered from control cells. To quanti- 
tate activity, the active eluted fractions from each column 
were pooled separately and tested in a kinetic assay. The results 
presented in Fig. 3 show a linear increase in optical density 
monitored from 1 to 6 h.  Units of enzyme activity calcu- 
lated as described in Materials and Methods revealed a total 
recovery of 27.8 U from control cells versus 248 U from UV 
light-treated  ceils.  These  results  indicate  that  UV  light 
treatment caused almost a 10-fold increase in the activity of 
DK120-binding enzymes. We were unable to isolate any UV 
light-activated protease using control columns of Sepharose 
6B, indicating that this enzyme does not bind to the uncon- 
jugated resin (data not shown). 
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Figure 4.  Semipurified protease activates DNA fragmentation  in iso- 
lated nuclei. (A) Protease preparations pooled as described in Fig. 3 were 
tested at the indicated dilutions along with several  commercially available 
proteases for induction of DNA fragmentation in isolated U937 nuclei 
as described in Materials and Methods. (B) The protease pool isolated from 
UV light-treated cells was tested in the presence of the protease inhibitors 
DK120 and TPCK at 50 #M and ~1 antiprotease at 5 #g/m1. 
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lated U937 Nuclei.  The semipurified protease in material 
pooled as described in Fig. 3 did not induce apoptosis in whole 
U937 cells (not shown). However, when incubated with iso- 
lated U937  nuclei, the results presented in Fig.  4 A  show 
that both samples caused DNA fragmentation, although the 
pool derived from UV light-treated cells had much higher 
activity than that from control cells. The highest total pro- 
tein concentration of the pools tested was 80 #g/ml,  only 
a fraction of which was attributed to the semipurified pro- 
tease. In contrast, elastase, chymotrypsin, and trypsin, which 
tested at concentrations as high as 0.1  mg/ml, were com- 
pletely  inactive.  This  argues  against  the  possibility  that 
DNA-fragmenting activity is a nonspecific effect of any pro- 
tease incubated with isolated nuclei. Furthermore, the nu- 
clear DNA-fragmenting activity of protease isolated from UV 
light-treated cells was inhibited by DK120, TPCK, and an 
c~1  antiprotease  (Fig.  4  B).  This  suggests  that  the  semi- 
purified protease may directly or indirectly activate a nuclease 
endogenous to U937 nuclei. Alternatively, it may be argued 
that the protease modifies chromatin structure to make the 
DNA more susceptible to digestion by a nudease that may 
contaminate the protease preparation.  This possibility was 
tested  by  incubating  both  pools  with  naked  3H-labeled 
DNA isolated from U937 cells. The results shown in Table 
2 indicate that neither pool could digest DNA, in contrast 
to the commercially available nucleases tested in parallel. The 
sensitivity of the assay is demonstrated by the fact that DNase 
I at only 0.1 ng/ml and micrococcal nuclease at 2 U/ml gave 
clearly detectable signals. Therefore, it is unlikely that a con- 
taminating nuclease accounts for the ability of the protease 
preparations to activate DNA fragmentation in isolated nuclei. 
During apoptosis,  endonucleases cleave DNA in the linker 
regions to release fragments in multiples of 180 bp.  There- 
Table  2.  Semipurified Protease Preparations Do Not 
Have DNase Activity 
Percent DNA 
Sample*  Fragmentation~ 
U937 control protease  0 
UV light-activated 
U937 protease  0 
DNase  1  1.0 ng/ml  61 
DNase  1  0.1  ng/ml  29 
DNase  1  0.01 ng/ml  11 
Micrococcal nuclease  50 U/ml  72 
Micrococcal nuclease  10 U/ml  65 
Micrococcal nuclease  2 U/ml  50 
Micrococcal nuclease  0.4  U/ml  0 
* Aflhfity-purified protease was tested at a final dilution of 1:2 in the assay. 
:~ DNase activity was measured using purified U937 DNA as a substrate 
as described  in Materials and Methods. 
Figure  5.  Gd electrophoresis analysis of DNA fragmentation induced 
by affinity-purified protease in isolated  nuclei. U937 nuclei were incubated 
with af~nity-purified  protease derived from UV light-treated U937 cells 
as described  in Fig. 4 with and without oq antiprotease (5/~g/ml) or 
DK120  and TPCK (50/~M for 5 h), and then DNA was extracted and 
electrophoresed.  (Lane 1) molecular weight markers; (hne 2) nuclei plus 
protease; (lane 3) control nuclei; (lane 4) nuclei plus protease plus oq an- 
tiprotease;  (lane 5) nuclei plus protease plus DK120;  (lane 6) nuclei plus 
protease plus TPCK; (lane 7) nuclei plus at antiprotease  alone; (lane 8) 
nuclei plus DK120  alone;  (lane 9) nuclei plus TPCK alone. 
fore, gel electrophoresis was used to analyze DNA extracted 
from isolated nuclei after exposure to DK120 affinity-purified 
protease obtained from U937 cells exposed to UV light. The 
results show that isolated nuclei incubated with the semi- 
purifed protease released internudeosomal-sized DNA frag- 
ments to produce the electrophoretic "ladder" pattern typ- 
ical of apoptosis  (Fig.  5,  lane 2).  However, if the protease 
preparation was pretreated with c~1 antiprotease, DK120, or 
TPCK for I h before addition to the nuclei, DNA fragmen- 
tation was abolished (Fig. 5, lanes 4-6). The DNA from un- 
treated nuclei (lane 3) or from nuclei treated with protease 
inhibitors alone (lanes 7-9) remained in high molecular weight 
form. These results confirm that a DK120-binding protease 
can activate internucleosomal DNA cleavage in isolated U937 
nuclei. 
Complete Purification  ofU937 Protease  and Demonstration of 
DNA Fragmenting  Activity.  Protease from 5  x  101~  U937 
cells pretreated with UV light was purified by multiple sepa- 
rations on the DK120 affinity column. Active eluted frac- 
tions were pooled and applied to a heparin-Sepharose column. 
All protease activity bound to the column and was eluted 
with a NaC1 gradient (not shown).  In an effort to obtain 
pure enzyme suitable for amino acid sequencing, active frac- 
tions were further purified by use of an HPLC reverse phase 
C4 column. All fractions were tested for protease activity 
against the MAAPV substrate as well as the capacity to actb 
rate DNA fragmentation in isolated U937 nuclei. The results 
presented in Fig.  6 show that both activities coeluted with 
a peak of activity in fraction 41. These fractions were inac- 
tive against the trypsin substrate, BLT (data not shown). SDS- 
PAGE analysis of fraction 41 revealed a single band of 24 kD 
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Figure 6.  Purification  of U937 protease  by re- 
verse phase HPLC and demonstration of proteo- 
lytic and DNA fragmenting activity. Protease  de- 
rived from UV  light-treated U937 cells was 
purified by DK120 af~nity  and heparin-Sepharose 
chromatography as described in  Materials and 
Methods. The final  purification  step  by reverse  phase 
C4 HPLC, the activity  of  each fraction  in the pro- 
tease assay  against the MAAtrr substrate  (OD410), 
and the DNA fragmenting activity  against isolated 
U937 nuclei are shown above. The lower tracing 
reflects the total protein profile as detected  by ab- 
sorbance at 215 nm. 
by silver staining (Fig.  7). Although fraction 40 also had high 
activity in the DNA fragmentation  assay, it had very little 
activity against the synthetic substrate and contained no visible 
bands on a silver-stained gel (not shown). It is probable that 
the nuclear DNA fragmentation  assay is highly sensitive to 
minute  amounts  of the  24-kD protease,  which would not 
produce a strong signal in the protease assay. One possible 
explanation is that the synthetic substrate does not perfectly 
mimic the natural substrate, thus accounting for the greater 
sensitivity of the nuclear assay. The purified enzyme was highly 
unstable, in that all activity was lost after 48 h at 4~  thus 
preventing  further characterization  of the protease activity. 
This purification has been repeated on two other occasions 
with  similar  results. 
The results of the protease purification are summarized in 
Table 3. The units of protease activity present in the crude 
cell lysate were not calculated since most of this activity was 
due to irrelevant  non-DK120 binding  enzymes. 
An  attempt  to determine  the  NHz-terminal  amino  acid 
sequence of the reverse phase purified material  was unsuc- 
cessful, although we were able to obtain an amino acid com- 
position from the same sample (Table 4). The calculated yield 
of protein recovered revealed that a total of 1.8 #g had been 
applied to the amino  acid sequencer.  Since this  quantity is 
well above the lower threshold for sequencing at this facility, 
we conclude that the NH2 terminus of the purified protease 
was probably blocked. 
Figure  7.  SDS-PAGE analysis  of 
purified 24-kD U937 protease. Protease 
was purified  from UV light-treated U937 
cells, and the active fraction 41 from the 
reverse phase separation shown in Fig. 6 
was analyzed  by SDS-PAGE  under non- 
reducing conditions  (identical  results  were 
observed  under reducing conditions, not 
shown). 
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Discussion 
This investigation examined the role of protease activity 
in the mechanism  of apoptosis.  The findings  indicate that 
a 24-kD protease is involved in activating DNA fragmenta- 
tion in U937 cells undergoing apoptosis. This conclusion is 
supported by the following lines of evidence.  (a) DNA frag- 
mentation  in  U937 and  several other  cell lines  exposed to 
TNF or UV light  is suppressed by the protease inhibitors 
TPCK and DK120 (b) Activation of apoptosis by UV light 
caused an "~10-fold increase in the activity of a protease iso- 
lated by binding to DK120 affinity columns. (c) Purification 
to homogeneity revealed  a single peptide of 24 kD that had 
protease activity and also activated DNA fragmentation  in 
isolated  U937 nuclei. 
These findings provide the basis for a model of the mecha- 
nism  of apoptosis in  U937 cells.  We propose  that  normal 
U937 cells contain the 24-kD protease in an inactive proen- 
zyme form or else in an active form that is normally sequestered 
from its substrate. This is supported by the observation that 
DNA fragmentation  in  U937 cells  triggered by TNF  (12) Table  3.  Purification of a 24-kD  U937 Protease 
Purification step  Total protein  Protease activity  Total protease  Specific activity 
mg  U/ral  U  U/rag 
Cell lysate  245  ND  ND  ND 
DK120 affinity  4.10  27.6  4,960  1,210 
Heparin-Sepharose  0.14  38.9  777  5,557 
Reverse phase HPLC C4  0.0018  95  507  28,167 
ND,  not determined. 
or UV light (our unpublished observations) is not blocked 
by inhibitors of protein synthesis.  Low levels of a DK120- 
binding protease were recovered from normal U937 cells. This 
may be due to the artifactual activation of a proenzyme during 
cell lysis and purification.  Alternatively, it may reflect the 
low incidence of apoptosis occurring spontaneously in cell 
culture. 
Agents inducing apoptosis,  such as UV light, may directly 
or indirectly activate the 24-kD protease. It is known that 
UV light can cause structural modifications to proteins and 
could conceivably activate a latent form of the 24-kD pro- 
tease. Alternatively, UV light may inactivate a protease in- 
hibitor that would normally function to protect a cell from 
apoptosis.  If the UV light effect is indirect, the signal could 
be transduced by second messengers that activate the pro- 
tease (or inactivate the postulated protease inhibitor). Such 
signals could involve protein phosphorylation, since UV light 
Table  4.  Amino Acid Composition 
Residue  Residues/Molecule* 
Asx  25 
Thr  7 
Ser  15 
Glx  30 
Pro  6 
Gly  43 
Ala  17 
Val  16 
Met  3 
Ile  10 
Leu  22 
Tyr  5 
Phe  8 
His  7 
Lys  8 
Trp  ND* 
Arg  13 
" The number of residues/molecule was calculated based on a molecular 
mass  of 24 kD. 
ND, not determined. Acid hydrolysis does not allow quantitative recov- 
ery of tryptophan. 
has been shown to activate certain protein kinases participating 
in the UV response in other cells (31), and ionizing irradia- 
tion activates protein kinases leading to apoptosis in B lym- 
phocytes (32).  Alternatively, the UV signal may be trans- 
duced through the genexation of free radicals, which are known 
to modify the function of many proteins.  This possibility 
is supported by our unpublished observations that free rad- 
ical scavengers (e.g., ascorbate, iron chelators, etc.) can pro- 
tect U937  and other tumor cells from UV light-induced 
apoptosis. 
Once activated, the 24-kD protease presumably acts  on 
a substrate located in the nucleus, since we have shown that 
this enzyme activates DNA fragmentation in isolated U937 
nuclei. One possible substrate is an endonuclease that would 
normally be latent in the nucleus. Alternatively, the protease 
may cleave other molecules that in turn activate endogenous 
nucleases.  One  possible  candidate is  the  nuclear  enzyme 
pADPKp. This enzyme is activated in cells undergoing apop- 
tosis, and its inhibitors block DNA fragmentation in U937 
cells (12). Furthermore, a recent report indicates that pADPRp 
is proteolytically cleaved, yielding enzymatically active frag- 
ments in cells undergoing apoptosis induced by chemother- 
apeutic drugs (33).  However, a role for pADPRp in medi- 
ating nuclear events leading to DNA fragmentation has yet 
to be established. 
Previous studies have reported both generalized proteol- 
ysis (34) as well as specific proteolytic processing of precursor 
IL-1 (35) in cells undergoing apoptosis.  However, in these 
studies, experiments were not performed to address the ques- 
tion of whether the protease activity is an essential step in 
the apoptotic pathway or just an epiphenomenon. More re- 
cently, it has been shown that overexpression of recombinant 
IL-1B-converting enzyme (ICE)  induced apoptosis  in rat 
fihroblasts  (36), implicating this protease in signaling DNA 
fragmentation. ICE is a cysteine protease consisting of two 
active 20- and 10-kD subunits (37) that requires Asp at the 
P1 site  (38).  This differentiates ICE from the protease de- 
scribed here. Since proteolyticaUy active ICE was isolated from 
the cytosol of monocytes and the monocyte line THE1 (39), 
it appears  that synthesis of this protease is not sufficient to 
induce apoptosis in any cell line. The possible interaction of 
ICE with other proteases (e.g., with 24-kD U937 protease) 
required for signaling apoptosis deserves further investigation. 
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a role for proteolysis in apoptosis.  In agreement with our 
findings, it was reported that TPCK inhibits chemotherapeutic 
drug-induced apoptosis in HL-60 cells (40). However, since 
that study did not purify and characterize the putative pro- 
tease, it is not clear whether the observed effects could be 
attributed to a protease comparable to the one purified in 
this investigation. 
The suppressive  effects of certain protease inhibitors have 
implicated the involvement of a  serine protease in  TNF- 
mediated tumor cell lysis (41, 42). However, neither report 
indicated whether the target cells (L929 fibroblasts and SK- 
MEL-109) died by necrosis or apoptosis, which is a critical 
issue  since TNF  can induce either mode of cell death in 
different target cell types (43).  A  more recent report indi- 
cated that expression of increased levels of plasminogen acti- 
vator inhibitor-2 in HT-1080 fibrosarcoma cells correlated 
with resistance to lysis by TNF (44). Again, it was not specified 
whether the sensitive  cells died by apoptosis,  nor was the 
putative protease isolated. 
Evidence from a recent study of the effect of a variety of 
protease inhibitors on T  lymphocyte apoptosis induced by 
antibodies against the T cell receptor suggested two proteases 
may be involved (45).  One was postulated to be calpain or 
some other cysteine protease, whereas the other appeared to 
be a serine protease inhibited by diisopropyl fluorophosphate 
or PMSF. Since the serine protease was not isolated and charac- 
terized, it is not known if it may be related to the U937 pro- 
tease. Taken together, these findings raise the possibility that 
apoptosis signal transduction may involve a proteolytic cas- 
cade.  Indeed, we have unpublished evidence for activation 
of multiple proteases that cleave substrates different from the 
elastase-like  substrate preferred by the 24-kD protease from 
apoptotic U937 cells. It is now clear that mechanisms of apop- 
tosis may differ depending on the inducing agent, and there- 
fore the protease described in this communication may be 
unrelated to enzymes involved in anti-T cell receptor-induced 
apoptosis  (45). 
Analysis of the mechanism of ceU-mediated cytotoxicity 
has led to the discovery of several proteases that may be in- 
volved in apoptosis in this system. According to the granule 
exocytosis modal of cell-mediated cytotoxicity (for review see 
references 46,  47),  after recognition of the target cell,  the 
effector cell (CTL or NK cell) releases cytoplasmic granules 
that contain lytic mediators, including cytolysin and a family 
of serine proteases (granzymes). Cytolysin is a pore-forming 
molecule that may act to promote entry of the proteases into 
the target cell. Recent studies have shown that in the pres- 
ence of cytolysin, or using detergent-permeabilized target cells, 
purified granzyme A/fragmentin 1 (48, 49) and fragmentins 
2 (50) and 3 (49) can activate DNA fragmentation. Further 
studies suggest that fragmentin 2 may act by inducing the 
premature activation of the p34  ~2 protein kinase that nor- 
mally functions to control cell entry into mitosis (51). How- 
ever, the characteristics of these enzymes, summarized in Table 
5,  indicate that they are clearly distinct from the protease 
we isolated from U937 with regard to molecular weight and 
substrate preference. Granzyme B and fragmentin 2 cleave 
tripeptide thiobenzyl ester substrates after aspartic acid, in 
contrast to the 24-kD U937 protease, which lacks Asp-ase 
activity. Further evidence suggests that our enzyme is not 
closely related to human granzyme B since the latter was 
reported to be inactive on methoxysuccinyl-Ala-Ala-Pro-Val- 
thiobenzyl ester (52), a substrate preferred by elastase-like en- 
zymes. Granzyme A/ffagmentin 1 and ffagmentin 3 are tryp- 
rases that cleave the BLT substrate. The completely purified 
U937 protease was inactive on the BLT substrate while medi- 
ating high activity on a synthetic substrate preferred by elastase- 
like enzymes. U937 cells are known to contain high levels 
of leukocyte elastase that can be isolated in two forms of 30 
and 60 kD (53).  In addition to the difference in molecular 
weight, the fact that commercially available leukocyte dastase 
Table  S.  The  U937 24-kD Protease Differs  from Leukocyte Elastase and Other Vroteases Implicated as Inducers of DNA Fragmentation 
Protease  Source  Molecular Mass  Substrate  Homolog  Reference 
24 kD protease  Humn U937 cells  24 kD reduced or nonreduced 
Granzyme A/Hanakah  Human CTL  30 kD reduced 
factor  60 kD nonreduced 
CCPI/Granzyme B  Murine CTL  35 kD reduced 
Fragmentin  1  Rat NK cell  30 kD nonreduced 
Fragmentin  2  Rat NK cell  31 kD nonreduced 
Fragmentin  3  Rat NK cell  27 kD nonreduced 
Leukocyte elastase  Human U937 cells  30 kD reduced 
60 kD reduced 
ICE  Monocytes  10- and 20-kD  subunits 
Ala-Ala-Pro-Val  ? 
BLT  Fragmentin  1 
Asp-ase 
BLT 
Asp-ase 
BLT 
Ala-Ala-Pro-Val 
IL-1B at 
Aspt16-Al#l~ 
47 
Fragmentin 2  50 
Granzyme A  48 
CCPl/Granzyme B  49 
Granzyme 3  48 
53 
None  36,  37 
2121  Wright et al. cannot induce DNA fragmentation in U937 nuclei (Fig.  4 
A) indicates that the protease we purified is not identical to 
leukocyte elastase. It is likely that the high levels of protease 
activity that did not bind to the DK120 affinity column may 
be attributed in part to leukocyte elastase. 
It is somewhat surprising that the DK120-binding pro- 
tease did not cleave the chymotrypsin substrate, SAAPP, which, 
like  DK120,  contains  Phe  at  Pl.  This  suggests  that  the 
peptide-binding activity of this enzyme does not strictly corre- 
late with proteolytic substrate specificity.  Work underway 
to clone and express the gene for this enzyme should provide 
quantities of protease sufficient for further characterization 
of substrate preferences and other activities. To the best of 
our knowledge, the 24-kD U937 protease appears to be dis- 
tinct from other known proteases. Efforts are underway to 
repurify this enzyme and obtain amino acid sequences from 
tryptic fragments. The results of this investigation provide 
the basis for further analysis of the mechanism of action of 
this protease in the U937 model system as well as explora- 
tion as of its involvement in other examples of apoptosis. 
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